Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $875.00, with a market capitalization of 829.24B. The stock trades at a price-to-earnings (P/E) ratio of 39.08 and offers a dividend yield of 69.5%.
As of 2026-03-28, Eli Lilly(LLY) stock has fluctuated between $872.51 and $901.15. The current price stands at $875.00, placing the stock +0.3% above today's low and -2.9% off the high.
Eli Lilly(LLY) shares are trading with a volume of 2.74M, against a daily average of 3.1M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.
LLY News
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 By Michael Williams Published Mar 28, 7:15AM EDT Quick Read VanEck...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The Phase 1 trial “A Study of LY4268989 (MORF-057) in Healthy Participants” ai...
Key Points One of these companies' lineup and pipeline within weight management and outside look much stronger. Valuation does not tip the scale in the other'...
Analyst ratings
83%
of 35 ratingsMore LLY News
Eli Lilly (LLY), has reported strong results form a clinical trial involving its new medication to treat the eczema skin condition. Claim 30% Off TipRanks Premi...
New long-term data show Eli Lilly (LLY) and Company’s EBGLYSS delivered durable skin clearanceandrelief from persistentitch for up to four years for patients wi...
Key Points Eli Lilly's GLP-1 drugs Mounjaro and Zepbound are industry leaders. Mounjaro and Zepbound are driving the company’s impressive revenue growth. Inv...
Eli Lilly recently reported strong Phase 3 results for its investigational triple-agonist retatrutide in type 2 diabetes and positive pediatric data for EBGLYSS...
Peptides, the gray-market supplements that have flooded Silicon Valley, may soon make their way into the mainstream. Who stands to benefit? Peptides are a stap...
Advertisement Stock performance snapshot Eli Lilly (LLY) has seen its share price retreat recently, with a 1 day return of 0.8%, a 1 week move of 2.9%, and a...
Key Points The healthcare sector is selling off in lockstep with the broader market. Eli Lilly’s growth is heavily dependent on weight loss drugs. The health...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.